The effect of atorvastatin therapy on tumour necrosis factor-α and vascular adhesion molecules in patients with type 2 diabetes mellitus with no prior history of coronary heart disease

Míreanna comhchosúla

• Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).
  de réir: Colhoun, H, et al.
  Foilsithe / Cruthaithe: (2009)
• Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.
  de réir: Colhoun, H, et al.
  Foilsithe / Cruthaithe: (2004)
• Erratum: Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: The Collaborative Atorvastatin Diabetes Study (CARDS)
  de réir: Charlton-Menys, V, et al.
  Foilsithe / Cruthaithe: (2009)
• Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS).
  de réir: Raikou, M, et al.
  Foilsithe / Cruthaithe: (2007)
• Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS).
  de réir: Charlton-Menys, V, et al.
  Foilsithe / Cruthaithe: (2009)